16 results for “Standard therapy”

Set a search alert

Research ArticleOpen accessIn the abstractIn-Depth Review of Human Immunodeficiency Virus-Associated NephropathySira Korpaisarn, Wisit Cheungpasitporn, Daych Chongnarungsin et al.Human Immunodeficiency Virus (HIV)-Associated Nephropathy (HIVAN) is one of the most important renal complications found in HIV-infected individuals. Morbidity and mortality in this group of patients increases due to End-Stage Renal Disease (ESRD). Classic histological characteristics of HIVAN are collapsing Focal Segmental Glomerulosclerosis (FSGS), microcystic tubular dilation and interstitial inflammation and fibrosis. High prevalence of HIVAN among people of African … …Current Research in Medicine, Vol. 4, Issue 1 · 19 Apr 2013 · 7,360 accessesView PDF Cite

Research ArticleOpen accessIn the abstractComparative Study of Antibacterial Susceptibility Patterns of the Bacteria Isolated from Patients' Blood Samples over Two PeriodsAziz Japoni, Mehdi Kalani, Abdolvahab Alborzi et al.Problem statement: Due to continuous changes in the frequencies and antibacterial susceptibility patterns of nosocomial pathogens, periodical surveillance of these fluctuations could help the clinicians to treat hospitalized patients more efficiently whenever empirical therapies need to be considered. This study was conducted to compare the prevalence of the bacteria recovered from bloodstream samples by Bactec 9240, over the two periods … …American Journal of Infectious Diseases, Vol. 7, Issue 1 · 27 Apr 2011 · 8,158 accessesView PDF Cite

Research ArticleOpen accessIn the abstractRole of Hematological and Alternate Markers in Human Immunodeficiency Virus Disease ProgressionK. V. Ramana, Jagadeeshwara Chary, V. Sabitha et al.Problem statement: The knowledge of HIV infection has expanded tremendously which has led to significant improvement in the treatment, leading to decrease in morbidity and mortality. Considering the limitations in using CD4+T-cell counts and HIV RNA viral load as markers in the HIV disease progression, physicians treating the HIV patients now look for alternate markers that predict HIV disease progression … …Current Research in Medicine, Vol. 1, Issue 2 · 31 Oct 2010 · 7,372 accessesView PDF Cite

Research ArticleOpen accessIn the abstractA New Proposed Statistically-Derived Compromise Cut-off CD4 Count Value for HIV Patients to Start using ARVsMaria Mokgadi Lekganyane, Solly Matshonisa SeeletseThe study investigated the relationship between statistical outliers and the inconsistent values of the CD4 count recommended for starting the Antiretroviral Therapy (ART) by HIV-positive patients. Low CD4 counts imply a low immune system. It could be due to AIDS existence or closeness to death. An effective treatment to curb HIV impact is ART, which is recommended for low CD4 … …American Journal of Applied Sciences, Vol. 13, Issue 7 · 29 Jun 2016 · 7,333 accessesView PDF Cite

Research ArticleOpen accessIn the abstractSusceptibility and Detection of Extended Spectrum β-Lactamase Enzymes from Otitis Media PathogensEjikeugwu Chika, Iroha Ifeanyichukwu, Adikwu Michael, Esimone CharlesOtitis media is the bacterial infection of the middle ear usually accompanied with inflammation, effusions and pain. It can present clinically in two major forms: Acute Otitis Media (AOM) and Otitis Media with Effusion (OME) and it is one of the leading cause of hospital visits and antibiotic prescriptions amongst children and even adults. Antibiotic resistance is a global public … …American Journal of Infectious Diseases, Vol. 9, Issue 1 · 21 Mar 2013 · 7,970 accessesView PDF Cite

Research ArticleOpen accessAll words, across the recordAssociation of Remdesivir with Poor Clinical Outcomes in COVID-19-A Single Center ExperienceRajat Ranka, Arjun, Prasan Kumar Panda et al.The need for an antiviral against COVID-19 prompted clinical trials worldwide and based on initial promising trends, remdesivir was widely used, including in India (compassionate use). Subsequent trials have been conflicting in their results and the utility of the drug has been widely debated. This is a record-based retrospective cohort study in a 1000-bedded government teaching hospital in North India. … …American Journal of Pharmacology and Toxicology, Vol. 17, Issue 1 · 3 Jun 2022 · 7,210 accessesView PDF Cite